Robert S. Habib
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.
Journal: Frontiers in medicine
Published: February 18, 2026
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.
Journal: Cell reports. Medicine
Published: November 16, 2023
Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic Syndrome.
Journal: Nucleic acid therapeutics
Published: July 27, 2022
MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models.
Journal: International journal of molecular sciences
Published: July 25, 2021
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 17, 2021
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 31, 2020
Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile.
Journal: Molecular therapy. Nucleic acids
Published: May 22, 2019
Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 29, 2018
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 23, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026